Physician profile
Tara Dethmers
NPI 1871049635
$700.05
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $288 · 2023: $377 · 2024: $35.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $171.26 | 2023 | Myrisk |
| Coopersurgical, INC. | $134.63 | 2022 | |
| Novo Nordisk INC | $130.73 | 2023-2024 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $77.04 | 2022-2023 | |
| Exeltis, USA INC. | $59.38 | 2022-2024 | Slynd |
| Avion Pharmaceuticals | $25.08 | 2023 | Balcoltra |
| Amgen INC. | $24.96 | 2022 | |
| Organon LLC | $23.63 | 2023 | Nexplanon |
| Abbvie INC. | $22.81 | 2022 | |
| Pfizer INC. | $12.64 | 2022 | |
| Evofem Biosciences, INC. | $11.64 | 2022 | |
| Mayne Pharma Commercial LLC | $6.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Dethmers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.